Sector: MedicalCephalon, Inc. (NASDAQ: CEPH)
Headlines
- King Beats, But Earnings Down
Nov 05, 2009 04:13 PM | ALO, CEPH, KG, OMRI, PTIE, ZGEN
- MFI Stock Review: Cephalon (CEPH)
Nov 05, 2009 01:01 PM | CEPH
- Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
Nov 05, 2009 11:00 AM | CEPH
- Cephalon, Inc. to Webcast R&D Day
Nov 04, 2009 02:00 PM | CEPH
- Dr. Stockpick Announces Daily Stock Watch - XOMA, DDRX, CEPH
Nov 03, 2009 10:05 AM | CEPH, PEET, XOMA
- Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder
Nov 02, 2009 04:30 PM | CEPH
- Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
Oct 27, 2009 04:10 PM | CEPH
- Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Oct 27, 2009 09:19 AM | CEPH
- Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Oct 26, 2009 08:22 AM | CEPH
- Cephalon Notified of Generic Filing for Armodafinil Tablets
Oct 21, 2009 04:06 PM | CEPH, TEVA
- Biotech firm Cephalon 3Q profit falls 2.7 percent
Oct 27, 2009 06:54 PM | CEPH
- Xoma Raises $13.9 Million in Equity Financing
Oct 05, 2009 05:53 AM | CEPH, XOMA
- Omniture Deal a Milestone for Utah's Tech Sector: The $1.8 Billion Price Tag Would Make It the Largest Such Deal in the State's History.
Sep 16, 2009 01:53 PM | ADBE, ATRS, CEPH, NOVL, OMTR, SYMC
- Cephalon Q1 Net Income Up
May 06, 2009 07:56 AM | CEPH
- Cephalon Offers A$318 Million to Acquire Arana
Feb 27, 2009 08:58 AM | CEPH
- Peachtree Mall Owner May Seek Bankruptcy Protection: Mall's Firm Wrestling With High Debt, Slumping Retail Sales
Nov 13, 2008 04:02 AM | CEPH, DDS, FD, GGP, JCP, M
- Cephalon Completes Acquisition of Arana Therapeutics
Aug 10, 2009 04:00 PM | CEPH
- BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Aug 06, 2009 06:53 AM | ARNA, AVII, AZN, BMR, CEPH, EPCT
- Cephalon Delivers Record Sales in the Second Quarter 2009 ; Sales and Adjusted Net Income Exceed Guidance; NUVIGIL Launch Off to Strong Start
Aug 04, 2009 06:51 PM | CEPH
- Cephalon Delivers Record Sales in the Second Quarter 2009
Aug 04, 2009 04:10 PM | CEPH
- Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia
Aug 03, 2009 04:11 PM | CEPH
- Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
Jul 31, 2009 09:00 AM | CEPH
- Cephalon Quarterly Conference Call Invitation
Jun 30, 2009 11:35 AM | CEPH
- Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
Jun 30, 2009 08:02 AM | CEPH
- Friday's News Makers - CarMax, Toyota, Cephalon, Harley Davidson, Electronic Arts; Research by InvestorSoup.com
Jun 19, 2009 01:00 PM | CEPH, ERTS, HOG, KMX, TM
- Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Jun 19, 2009 08:30 AM | CEPH
- Form 4 Baldassano Valli F. For: Sep 21 (10K)
Sep 22, 2009 11:19 AM
- Form 4 WINGER DENNIS L For: May 12 (10K)
May 13, 2009 11:24 AM
- Form 4 WILENSKY GAIL R For: May 12 (10K)
May 13, 2009 11:18 AM
- Form 4 CEPHALON INC For: May 12 Filed by: SANDERS CHARLES A (10K)
May 13, 2009 11:13 AM
- Form 4 MOLEY KEVIN E For: May 12 (10K)
May 13, 2009 11:04 AM
- Form 4 GREENACRE MARTYN D For: May 12 (10K)
May 13, 2009 10:28 AM
- Form 4 CEPHALON INC For: May 12 Filed by: EGAN WILLIAM P (10K)
May 13, 2009 10:09 AM
- Form 4 CEPHALON INC For: Feb 02 Filed by: BALDINO FRANK JR (10K)
Feb 03, 2009 11:40 AM
- Form 4 GREBOW PETER E For: Jan 22 (10K)
Feb 03, 2009 11:30 AM
- Form 4/A SAVINI CARL A For: Dec 11 (10K)
Jan 20, 2009 04:41 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CEPH
|
Compare to S&P
|
| YTD |
-29.15 %
|
-38.24 %
|
| 4 Weeks |
-1.83 %
|
-2.87 %
|
| 12 Weeks |
-3.59 %
|
-5.98 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 12.50 %
|
|
EPS Growth in Last Year: 37.29 %
|
|
Sales Growth in Last Quarter: 0.29 %
|
|
Sales Growth in Last Quarter: 10.22 %
|
|
